Last €4.23 EUR
Change Today +0.116 / 2.82%
Volume 5.1M
EVT On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
Frankfurt
As of 10:37 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for evotec ag (EVT)

Year over year, Evotec AG has seen net income shrink from a gain of €2.5M EUR to a loss of €25.4M EUR despite relatively flat revenues. A key factor has been an increase in the percentage of sales devoted to income tax expense from -8.59% to 2.08%.
View Income Statement In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2010
EUR
Dec 31
2011
Reclassified
EUR
Dec 31
2012
Reclassified
EUR
Dec 31
2013
EUR
4 Year
Trend
Revenues55.380.187.385.9
TOTAL REVENUES55.380.187.385.9
Cost of Goods Sold30.945.156.254.7
GROSS PROFIT24.335.031.031.2
Selling General & Admin Expenses, Total16.015.816.316.6
R&D Expenses6.18.48.39.7
Depreciation & Amortization, Total0.71.72.83.2
Other Operating Expenses-0.23.42.10.0
OTHER OPERATING EXPENSES, TOTAL22.629.329.529.4
OPERATING INCOME1.85.71.51.8
Interest Expense-0.9-1.9-1.9-1.9
Interest and Investment Income1.20.41.10.3
NET INTEREST EXPENSE0.4-1.4-0.8-1.6
Currency Exchange Gains (Loss)2.71.4-1.2-0.6
Other Non-Operating Income (Expenses)-0.20.20.20.0
EBT, EXCLUDING UNUSUAL ITEMS4.75.8-0.3-0.3
Merger & Restructuring Charges-------0.5
Impairment of Goodwill-------1.9
Gain (Loss) on Sale of Investments-0.8-0.1---0.2
Gain (Loss) on Sale of Assets0.00.1-0.1-0.1
Other Unusual Items, Total---0.6-4.6-20.6
Other Unusual Items-----1.12.5
EBT, INCLUDING UNUSUAL ITEMS3.95.3-5.0-23.6
Income Tax Expense0.9-1.4-7.51.8
Minority Interest in Earnings0.30.1----
Earnings from Continuing Operations3.06.72.5-25.4
NET INCOME3.36.72.5-25.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS3.36.72.5-25.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS3.36.72.5-25.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVT:GR €4.23 EUR +0.116

EVT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Array BioPharma Inc $4.20 USD -0.08
CTI BioPharma Corp $2.63 USD -0.035
Exelixis Inc $4.23 USD +0.02
Galapagos NV €14.44 EUR -0.18
GlaxoSmithKline SAE £13.00 EGP 0.00
View Industry Companies
 

Industry Analysis

EVT

Industry Average

Valuation EVT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.8x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOTEC AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.